MC
OACC

Meteora Capital’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Meteora Capital’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Sell
182,093
-8,885
-5% -$94.6K 0.14% 124
2025
Q4 		$2.02M Sell
190,978
-57,522
-23% -$609K 0.17% 108
2025
Q3 		$2.61M Buy
248,500
+199,000
+402% +$2.08M 0.28% 82
2025
Q2 		$517K Buy
+49,500
New +$513K 0.1% 84

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Meteora Capital's OACC Position: Q1 2026 in Review

Meteora Capital reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 4.7% in Q1 2026, selling an estimated $94.6K and leaving 182,093 shares worth $1.93M. The position accounts for 0.14% of the portfolio, ranked #124.

Meteora Capital first reported a position in OACC in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.61M in Q3 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Meteora Capital held 182,093 shares of Oaktree Acquisition Corp III Life Sciences worth $1.93M as of Q1 2026.
  • Meteora Capital sold 8,885 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $94.6K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.14% of Meteora Capital's portfolio in Q1 2026, its #124 holding.
  • Meteora Capital first reported a position in Oaktree Acquisition Corp III Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Meteora Capital's Oaktree Acquisition Corp III Life Sciences position peaked at $2.61M in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.